Champion Gamine To Visit Quality Road For First Mating

Gamine, the champion female sprinter of 2020 and an Eclipse Award finalist for the same title in 2021, will visit Lane's End resident Quality Road for her first mating, bloodstock agent Donato Lanni announced Feb. 6 on social media.

The 5-year-old daughter of Into Mischief retired with nine wins in 11 starts for earnings of $1,771,500.

Gamine topped the 2019 Fasig-Tipton Midlantic 2-Year-Olds in Training Sale after selling to owner Michael Lund Petersen for $1.8 million. She secured the Eclipse Award as champion female sprinter at age three, with victories in the Grade 1 Acorn Stakes and Test Stakes, and a capstone score in that year's Breeders' Cup Filly and Mare Sprint at Keeneland.

Gamine won the first four starts of her 2021 campaign, ticking off wins in the G3 Las Flores Stakes, G1 Derby City Distaff Stakes, G2 Great Lady M Stakes, and G1 Ballerina Handicap. Her final start saw her finish third in the Breeders' Cup Filly and Mare Sprint at Del Mar.

Bred in Kentucky by Grace Thoroughbred Holdings, Gamine is out of the stakes-placed Kafwain mare Peggy Jane.

Quality Road, 16-year-old son of Elusive Quality, stands at Lane's End in Versailles, Ky., for an advertised fee of $150,000.

From nine crops of racing age, Quality Road has sired 432 winners and amassed combined progeny earnings of more than $65.2 million.

Quality Road has sired two Eclipse Award winners: Champion 2-year-old filly Caledonia Road and champion 3-year-old female Abel Tasman. Corniche, the winner of last year's Breeders' Cup Juvenile, is a finalist – and the presumptive favorite – for champion 2-year-old male of 2021.

He is also responsible for Pegasus World Cup winner City of Light, Breeders' Cup Juvenile Turf winner Hootenanny, and Grade 1 winners including Dunbar Road, Bellafina, Spring Quality, Roadster, Salty, Illuminant, and Klimt.

Source of original post

Gamine to Visit Quality Road in 2022

Michael Lund Petersen's Gamine (Into Mischief) has been booked to Lane's End stallion Quality Road for 2022, bloodstock agent Donato Lanni confirmed Sunday.

“We had a meeting with Michael to decided what to do and we all agreed that Quality Road was the right horse to start off her broodmare career,” Lanni said. “You really can't go wrong with Quality Road–he's a very good sire.”

Acquired for $1.8 million at the 2019 Fasig-Tipton Midlantic 2-Year-Olds in Training Sale, Gamine won nine of 11 starts, including the 2020 GI Breeders' Cup F/M Sprint, GI Acorn S. and GI Test S. and was named the year's Eclipse champion female sprinter.

In 2021, she added wins in the GI Derby City Distaff and GI Ketel One Ballerina S. and she concluded her career with a third-place finish in the Breeders' Cup F/M Sprint. She is once again an Eclipse award finalist as top female sprinter.

Gamine's retirement was announced in early January and the 5-year-old mare currently resides at Hill 'n' Dale at Xalapa Farm in Paris, Kentucky.

“She's happy,” Lanni said. “She's turned out with some fillies, she's really happy to have some buddies now at Xalapa. She's enjoying retirement.”

Asked if the champion might be offered at auction next fall, Lanni said, “We just want to get her bred, get her pregnant. We're not even thinking about that right now.”

The post Gamine to Visit Quality Road in 2022 appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Baffert Takes Stand In NYRA Hearing; KY Hearing Next

Bob Baffert testified for about 3 1/2 hours in Thursday's hearing to determine whether the New York Racing Association (NYRA) can exclude the trainer over alleged “detrimental conduct.” Much of the testimony consisted of exchanges between the Hall of Fame trainer and NYRA attorney Hank Greenberg, whose attempts to rattle Baffert were largely unsuccessful. The Hall of Famer stuck to what has been the narrative from his team since the issues of his repeated medication violations first arose–that each offense involved mitigating circumstances that explain why he wasn't deserving of serious sanctions.

During a marathon day of testimony, it was revealed by Baffert that the Kentucky Horse Racing Commission has finally set a date, Feb. 7, to begin to delve into the matter of Medina Spirit (Protonico) testing positive for betamethasone in the 2021 GI Kentucky Derby. Baffert said he was told of the hearing by attorney Clark Brewster. The Kentucky commission has yet to make any announcements regarding the date of a hearing over the Medina Spirit matter.

Typical during the NYRA hearing was the back-and-forth between Baffert and Greenberg on the subject of Gamine (Into Mischief) testing positive for betamethasone following her third-place finish in the 2020 GI Kentucky Oaks. Baffert has maintained that he gave Gamine the medication 18 days prior to the race when the rules only prohibit its use within14 days of a start.

“You ran a horse that was disqualified from the most important race for 3-year-old fillies in America, isn't that right? That is a very significant outcome, isn't it?” Greenberg asked

“That was an unjustified outcome,” Baffert replied.

Greenberg also brought up Baffert's announcement in November 2020 that he was hiring Dr. Michael Hore of Hagyard Equine Medical Institute “to add an additional layer of protection to ensure the well-being of horses in my care and rule compliance.” Hore later revealed that he never went to work for Baffert. Baffert said that the only thing that kept Hore from fulfilling those duties was the pandemic.

“You didn't do it Mr. Baffert,” Greenberg said of his promise to bring Hore on aboard. “True or not?”

“It couldn't be done because of COVID,” Baffert replied. “He was going to come in January but he couldn't make it.”

“Is that your way of saying, no, I didn't hire Dr. Hore?” Greenberg said in response. “You did not hire him.”

“He couldn't make it because of COVID,” Baffert said. “He couldn't get there until late spring.”

The hearing soon turned to Baffert's series of press conferences and interviews after it was revealed that Medina Spirit had tested positive. Greenberg alleged that Baffert's media tour hurt the sport because he brought up such things as conspiracy theories. For Baffert, his response marked a rare time where he did admit to some guilt. At the end of the hearing he said if he had to do it over again he would not have granted those interviews.

“I used the word 'cancel culture' and what I meant to say was 'knee jerk,'” Baffert said. “To say 'cancel culture' was a bad move on my part.”

But Baffert said he made such statements because he was under duress.

“I was pretty upset,” Baffert said. “That was just raw emotion, knowing that I did not inject that horse with betamethasone. I knew something was not right.”

When asked if he understood that what he said was harmful to the reputation of the sport, Baffert replied: “This was something that really hit me hard. This is the Kentucky Derby, the greatest race. This is a trainer's nightmare.”

Before Greenberg had his turn, Baffert attorney Craig Robertson led the trainer through a series of questions that included his take on what happened with Medina Spirit. Baffert reiterated his contention that the drug got into the horse's system not through an injection but through the use of a topical ointment, Otomax, to deal with a skin condition. Baffert, who, at first, said that it was impossible that betamethasone was in Medina Spirit's system, said he did so because it never crossed his mind that the drug could be present in a skin ointment. It's notable, however, that it clearly says on Otomax boxes that the ointment contains betamethasone.

Baffert acknowledges that the controversy has affected both him and his family and added that the horses taken away from him include Life Is Good (Into Mischief), who he called the “best horse training in America.”

“It's been rough and tough,” he said. “But it's one of those things where we know we have the facts and the truth. It's probably tougher on my children.”

The hearing started with testimony from Dr. Clara Fenger, a former state vet for the Kentucky Horse Racing Commission. Robertson went through the various drug positives Baffert has been hit with and asked with each one if the drugs involved were performance-enhancing, able to mask any injuries and had any pharmacological effect. Fenger answered no on each occasion.

Next up was Dr. Steven Barker, the long-time director of the Equine Medication Surveillance Laboratory and state chemist to the Louisiana Racing Commission. Like Fenger, Barker said that none of Baffert's violations were particularly serious.

“There's nothing here that matches the rhetoric that has surrounded this case and the actions of NYRA,” he said. “None of this can be considered doping. None of this can be considered an attempt to affect performance. These are common therapeutics at extremely low levels.”

The hearing will resume Friday, with closing statements expected.

The post Baffert Takes Stand In NYRA Hearing; KY Hearing Next appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Baffert Reveals New Details About Medina Spirit Case In Day 4 Of NYRA Hearing

Testimony continued Jan. 27 in the hearing held by the New York Racing Association to determine whether it can suspend trainer Bob Baffert. NYRA had rested its case Jan. 26, and Thursday's session was comprised of witnesses called by Baffert's attorneys, including Dr. Clara Fenger, board member of the North American Association of Racetrack Veterinarians (NAARV), Dr. Steven Barker, formerly laboratory director for Louisiana's post-race drug testing laboratory, and Baffert himself.

Part of Thursday's proceedings would appear to have previewed Baffert's side of the case in the drug positive of Medina Spirit following the Kentucky Derby. During cross examination, Baffert confirmed that a hearing in the case has been scheduled with the Kentucky Horse Racing Commission for Feb. 7.

Baffert and the other witnesses Thursday made reference to the results of extra drug testing on remaining urine samples taken from Medina Spirit by Dr. George Maylin, head of the drug testing laboratory for the New York State Gaming Commission. According to a statement from Maylin read into the record, testing on those samples revealed the presence of betamethasone valerate, which is present in Otomax but not in the injectable form of betamethasone given to horses. It did not reveal the presence of betamethasone acetate, which is the form of the drug that's used in injectable products for horses. The tests also purportedly revealed the presence of clotrimazole, an anti-fungal medication which is also present in Otomax.

Baffert has said Medina Spirit's positive test was the result of Otomax treatment for a troublesome skin rash on the horse's hindquarters. He said on Thursday that the rash was at various times also on the horse's girth area and neck. Initially, Baffert said veterinarian Dr. Vince Baker suggested using a couple of shampoos to try, and when those didn't work on the rash, Baker prescribed Otomax and Dermacloth. Dermacloth is an over-the-counter grooming wipe product designed to combat certain types of skin problems in horses.

Baffert has previously said the rash appeared some time after the Santa Anita Derby, several weeks before the colt's victory in Louisville. He has also said the Otomax treatment ended the day before the Kentucky Derby.

Baffert said one of his first calls after learning about the test was to Baker, but that Baker did not suggest to him that Otomax could be the source of the betamethasone until Monday afternoon, the day after Baffert's press conference announcing the positive test. Baffert represented that Baker was as surprised as Baffert was by the positive test. Baffert said that after Gamine tested positive for the same drug following the 2020 Kentucky Oaks, he ordered his veterinarians to stop using betamethasone for joint injections and that he wanted the drug “out of my barn” after that.

The ointment was applied by a groom, according to Baffert.

Additional highlights from Thursday:

  • Both Barker and Fenger testified that the concentrations of the therapeutic medications found in Baffert's horses for the period of time in question could not have had an impact on the horses' performance, or any therapeutic impact on the horses themselves. This is in conflict with Dr. Pierre-Louis Toutain, the expert called by NYRA, who testified on Tuesday regarding betamethasone and phenylbutazone.
  • Fenger opined that in many states, the first two violations in question in NYRA's charges, both overages in California for phenylbutazone within a week of each other in summer 2019, would normally have been combined into one ruling. It is common practice in some places to combine violations that occur close together because the commission may not have had the chance to notify the trainer about the first violation before subsequent ones occur, thereby preventing the trainer's ability to change their medication or barn management plans.
  • Maylin and Fenger, who worked together on the additional testing of the Medina Spirit samples, used two research horses to help develop new tests for the components of Otomax. Maylin intends to submit some of his findings to a peer-reviewed journal for publication.
  • Fenger also questioned the science behind Kentucky's betamethasone threshold, pointing out that it was developed from a study conducted on research horses rather than active racehorses.
    [Story Continues Below]
  • On cross examination from an attorney for NYRA, Fenger was asked about a technique Maylin has described that he said was designed to keep lidocaine or drugs like it localized in an area where it may be injected. Attorney Kelly McNamee said Maylin has testified to the addition of an oil depot and a vasoconstrictor like adrenaline to keep lidocaine from disappearing as quickly from tissues where it's been placed. McNamee never connected that method with anything Baffert has been accused of using. Fenger said she was not familiar with that kind of procedure being used in horses.
  • Veterinary records from Baffert's barn show “a lot” of his horses around the time of the 2019 bute violations were given bute two days ahead of a race, according to McNamee. Fenger said this practice, called “pre-racing,” is not standard for all trainers, but is also not unusual and is done even when the horse is not showing signs of soreness or lameness.
  • Barker testified to his concern that increased sensitivity of drug testing in racing will eventually result in more damage than benefit to racing.“It's unfortunate that such insignificant findings can result in prosecution,” said Barker, referring specifically to a finding of dextrorphan in Baffert runner Merneith in July 2020. “The mere presence of a drug does not necessarily result from nefarious action … rather than protect the integrity of the sport, such prosecutions continue to damage the image of the industry and trainers, owners, and horses. It is also unfortunate that the state of California does not rely on the review of such data by qualified equine pharmacologists.”
  • Barker also said that he is not surprised Baffert, who has a large number of winners and therefore a large number of tested horses, has a number of positive findings. Under the current scheme, Barker said only 20 percent or so of horses in any given jurisdiction are ever tested, which means the rate of positives would be about five times higher if every horse were tested.“The idea that the more successful you are, the more likely you are to go to the test barn, the more likely you are to have trace levels of these drugs detected,” he said.Attorneys for NYRA said Baffert has been cited and paid fines on 14 separate occasions for Bute overages, though that figure may include his time spent training Quarter Horses.
  • Baffert admitted that his media tour after announcing Medina Spirit's betamethasone test was probably a mistake, and regretted using the “cancel culture” phrase that appeared in so many headlines after he referenced it on the Dan Patrick Show.“I probably shouldn't have used 'cancel culture,'” he said. “I should've just said knee jerk. The 'cancel culture' was a bad move on my part.”At the time of his mainstream media interviews that week, Baffert said he was extremely emotional, and also blamed the compressed timeframe for some of his public relations response. As in the Arkansas cases of Gamine and Charlatan, Baffert said someone had leaked the drug test results for Medina Spirit to the media, which forced his announcement about the positive in a press conference held outside his barn at Churchill Downs. He did not speculate on the origin of the leak.
  • Baffert also testified that he did not hear from NYRA with any questions or clarifications regarding the Medina Sprit case or any of the other drug positives at issue in the time leading up to the racing organization's decision to suspend him.“I was disappointed,” he said. “They were friends of mine. I felt betrayed, in a way. I'd gone up there and really just ran my horses. I wasn't there long, but I always showed up and ran all those races and for them to come out with that, I was a little bit surprised but mostly disappointed.”
  • Baffert takes issue with NYRA's characterization that he has had six positives in the timeframe cited by the organization. Because Gamine and Charlatan were ultimately restored to their finish positions in their respective races at Oaklawn Park in 2020 and the suspension handed down by the stewards was vacated, Baffert said he does not believe those incidents should count as positives. The official ruling, which was amended by the full Arkansas Racing Commission, still fined him $5,000 for each test in excess of allowable levels.He also maintains that the Kentucky case of Gamine was an unfair one because veterinarian Dr. Ryan Carpenter gave the horse a betamethasone injection 18 days prior to the 2020 Kentucky Oaks, well outside Kentucky's 14-day stand down guideline.
  • Baffert no longer attributes the lidocaine overages in Charlatan and Gamine at Oaklawn to assistant trainer Jimmy Barnes' use of an over-the-counter pain relief patch. He later learned that a third horse on the same race card had a testable level of a metabolite for the drug in its system, although the level was below the state's threshold for calling positives. He also said he had been told by an official there that there had been another cluster of three or four tests showing levels of lidocaine earlier in the meet, also below the threshold.

The hearing continues on Jan. 28.

 

The post Baffert Reveals New Details About Medina Spirit Case In Day 4 Of NYRA Hearing appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights